Procalcitonin as a Marker of Etiology in Adults Hospitalized with Community-Acquired Pneumonia

176Citations
Citations of this article
273Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background. Recent trials suggest procalcitonin-based guidelines can reduce antibiotic use for respiratory infections. However, the accuracy of procalcitonin to discriminate between viral and bacterial pneumonia requires further dissection. Methods. We evaluated the association between serum procalcitonin concentration at hospital admission with pathogens detected in a multicenter prospective surveillance study of adults hospitalized with community-acquired pneumonia. Systematic pathogen testing included cultures, serology, urine antigen tests, and molecular detection. Accuracy of procalcitonin to discriminate between viral and bacterial pathogens was calculated. Results. Among 1735 patients, pathogens were identified in 645 (37%), including 169 (10%) with typical bacteria, 67 (4%) with atypical bacteria, and 409 (24%) with viruses only. Median procalcitonin concentration was lower with viral pathogens (0.09 ng/mL; interquartile range [IQR], <0.05-0.54 ng/mL) than atypical bacteria (0.20 ng/mL; IQR, <0.05-0.87 ng/mL; P =.05), and typical bacteria (2.5 ng/mL; IQR, 0.29-12.2 ng/mL; P

Cite

CITATION STYLE

APA

Self, W. H., Balk, R. A., Grijalva, C. G., Williams, D. J., Zhu, Y., Anderson, E. J., … Wunderink, R. G. (2017). Procalcitonin as a Marker of Etiology in Adults Hospitalized with Community-Acquired Pneumonia. Clinical Infectious Diseases, 65(2), 183–190. https://doi.org/10.1093/cid/cix317

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free